Phase 0 Study of Normal Postpartum Involution to Identify the Feasibility of a Life Window for Breast Cancer Chemoprevention (COMIRB 12-0769)
This study will examine changes that occur in the breast tissue, blood and urine of a woman after she has given birth. The study will examine how cells change after pregnancy and breast feeding and how the immune system interacts with these changes. Study participants will be asked to have a one-time breast tissue biopsy, as well as a one-time blood and urine sample.
COMPENSATION: Study participants will be given a $300 gift card as compensation following completion of study.
You will be asked 5 eligibility questions about your medical and pregnancy history to determine if you qualify for this study. These questions will take less than 10 minutes to answer. While you may choose to skip a question, doing so will make you ineligible to participate.
Any information that would identify you from your survey (name, phone number, address & email) will not be recorded unless you are eligible. At that time, this information will be kept secure and only used to contact you for study purposes.
We are required to give you the number of COMIRB (303.724.1055), the Ethics Board that oversees our research.
In the case you have any questions or concerns please contact Emily Rozzo (303-724-6077 or Emily.Rozzo@ucdenver.edu)
Please answer the following questions below. If the survey ends early, you are not currently eligible to participate. Eligible persons will be prompted to give their contact information at the end.
Page 1 of 1
You have selected an option that triggers this survey to end right now. To save your responses and end the survey, click the
button below to do so. If you have selected the wrong option by accident and do not wish to leave the survey,
you may click the other button below to continue, which will also remove the value of the option you just selected
to allow you to enter it again and continue the survey.
The response has now been removed for the last question for which you selected a value. You may now enter
a new response for that question and continue the survey.